{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":26,"n_cols":5,"rows_kept":26,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[14,2,14,3],[14,4,14,5],[15,2,15,3],[15,4,15,5],[16,2,16,3],[16,4,16,5],[17,2,17,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[23,2,23,3],[24,2,24,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910647225803321"]
[null,null,"Titolo",null,"Biosimilars in Europe / / Arnold G Vulto, Steven Simoens, Isabelle Huys, editors"]
[null,null,"Pubbl/distr/stampa",null,"[Place of publication not identified] : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023"]
[null,null,"ISBN",null,"3-0365-6574-4"]
[null,null,"Descrizione fisica",null,"1 online resource (188 pages)"]
[null,null,"Disciplina",null,"658.1552"]
[null,null,"Soggetti",null,"Value analysis (Cost control)"]
[{"$nulls":4},"cost containment"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"About the Editors vii -- Emerging Insights into European Markets of Biologics, Including Biosimilars 1 -- Budget Impact Analysis of Biosimilar Products in Spain in the Period 2009-2019 5 -- Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria  21 -- Simulating Costs of Intravenous Biosimilar Trastuzumab vs. Subcutaneous Reference Trastuzumab in Adjuvant HER2-Positive Breast Cancer: A Belgian Case Study 31 -- Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany 39 -- Barriers to Biosimilar Prescribing Incentives in the Context of Clinical Governance in Spain 59 -- The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?  75 -- Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices 81 -- Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review 109 -- Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities 127 -- Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars  143 -- Informing Patients about Biosimilar Medicines: The Role of European Patient Associations 157."]
[null,null,null,"Sommario/riassunto","This reprint examines regulatory, pricing and reimbursement issues related to the market access and uptake of off-patent biologics, biosimilars, next-generation biologics and competing innovative "]
[{"$nulls":4},"medicines in European countries."]
[null,"2.","Record Nr.",null,"UNIORUON00432349"]
[null,null,"Autore",null,"ALVINO, Francesco"]
[null,null,"Titolo",null,"I calendari : ossia metodi di computare il tempo dai popoli antichi e dalle nazioni moderne / Francesco Alvino"]
[null,null,"Pubbl/distr/stampa",null,"598 p., 1 c. ripieg. ; 26 cm"]
[null,null,"Edizione",null,"[Firenze : Tipografia Egisto Bruscoli]"]
[null,null,"Descrizione fisica",null,"Sul front. ex libris e firma di G. E. Gerini"]
[null,null,"Classificazione",null,"INT VII"]
[null,null,"Soggetti",null,"CALENDARI - Storia"]
[{"$nulls":4},"CALENDARIO - Storia"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]